Geneus Biotech SAS

About Geneus

Geneus Biotech SAS is a technology company founded in 1997 and based in the 7th arrondissement of Paris (75007 Paris, France). With Geneus LBO™, the company offers physical deployment and simulation systems that enable customers to test, model and understand the physical vulnerabilities of critical electronic infrastructure systems before they turn into failures, damage events, outages or strategic risks. In addition, Geneus is developing LBO™ 1.0, synthetic bio-solutions to address global threats. The systems are aimed at operators of digital and critical infrastructure, particularly in electrified, automated and compute-intensive environments. Classical manufacturing with in-house production processes or machines is not documented on the website. Communication is conducted in English and French; contact via e-mail at info@geneus.fr or through the legal representative at hk@geneus.fr.

Site

Paris, France

Processes

Physical provisioning, testing, modeling and analysis of the physical vulnerabilities of critical, Synthetic bio-solutions (LBO™ 1.0)

Materials

Geneus LBO™, LBO™ 1.0

Founded

1997

Industries

Electronic Infrastructure, Critical Infrastructure

1. 01

   Consulting/Analysis

2. 02

   Modeling & Simulation

3. 03

   Physical Deployment & Testing

4. 04

   Vulnerability Assessment

Processes & Technologies

Locations

Paris

FR

Headquarters

History

1. 1997

   Foundation of the company; according to its own statement: "Since 1997, we have never followed any conventions."